205 related articles for article (PubMed ID: 26875499)
1. Genetic engineering and heterologous expression of the disorazol biosynthetic gene cluster via Red/ET recombineering.
Tu Q; Herrmann J; Hu S; Raju R; Bian X; Zhang Y; Müller R
Sci Rep; 2016 Feb; 6():21066. PubMed ID: 26875499
[TBL] [Abstract][Full Text] [Related]
2. Production of the tubulin destabilizer disorazol in Sorangium cellulosum: biosynthetic machinery and regulatory genes.
Kopp M; Irschik H; Pradella S; Müller R
Chembiochem; 2005 Jul; 6(7):1277-86. PubMed ID: 15892181
[TBL] [Abstract][Full Text] [Related]
3. Heterologous expression and genetic engineering of the tubulysin biosynthetic gene cluster using Red/ET recombineering and inactivation mutagenesis.
Chai Y; Shan S; Weissman KJ; Hu S; Zhang Y; Müller R
Chem Biol; 2012 Mar; 19(3):361-71. PubMed ID: 22444591
[TBL] [Abstract][Full Text] [Related]
4. Modular construction of a functional artificial epothilone polyketide pathway.
Osswald C; Zipf G; Schmidt G; Maier J; Bernauer HS; Müller R; Wenzel SC
ACS Synth Biol; 2014 Oct; 3(10):759-72. PubMed ID: 23654254
[TBL] [Abstract][Full Text] [Related]
5. Engineering Pseudochelin Production in Myxococcus xanthus.
Korp J; Winand L; Sester A; Nett M
Appl Environ Microbiol; 2018 Nov; 84(22):. PubMed ID: 30217842
[TBL] [Abstract][Full Text] [Related]
6. Heterologous expression of epothilone biosynthetic genes in Myxococcus xanthus.
Julien B; Shah S
Antimicrob Agents Chemother; 2002 Sep; 46(9):2772-8. PubMed ID: 12183227
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of the myxothiazol biosynthetic gene cluster by Red/ET recombination and heterologous expression in Myxococcus xanthus.
Perlova O; Fu J; Kuhlmann S; Krug D; Stewart AF; Zhang Y; Müller R
Appl Environ Microbiol; 2006 Dec; 72(12):7485-94. PubMed ID: 16997979
[TBL] [Abstract][Full Text] [Related]
8. Direct cloning, genetic engineering, and heterologous expression of the syringolin biosynthetic gene cluster in E. coli through Red/ET recombineering.
Bian X; Huang F; Stewart FA; Xia L; Zhang Y; Müller R
Chembiochem; 2012 Sep; 13(13):1946-52. PubMed ID: 22851214
[TBL] [Abstract][Full Text] [Related]
9. DKxanthene biosynthesis--understanding the basis for diversity-oriented synthesis in myxobacterial secondary metabolism.
Meiser P; Weissman KJ; Bode HB; Krug D; Dickschat JS; Sandmann A; Müller R
Chem Biol; 2008 Aug; 15(8):771-81. PubMed ID: 18721748
[TBL] [Abstract][Full Text] [Related]
10. Heterologous expression of the oxytetracycline biosynthetic pathway in Myxococcus xanthus.
Stevens DC; Henry MR; Murphy KA; Boddy CN
Appl Environ Microbiol; 2010 Apr; 76(8):2681-3. PubMed ID: 20208031
[TBL] [Abstract][Full Text] [Related]
11. Heterologous expression and genetic engineering of the phenalinolactone biosynthetic gene cluster by using red/ET recombineering.
Binz TM; Wenzel SC; Schnell HJ; Bechthold A; Müller R
Chembiochem; 2008 Feb; 9(3):447-54. PubMed ID: 18157854
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Functional Analyses of the DKxanthene Biosynthetic Gene Cluster from
Hyun H; Lee S; Lee JS; Cho K
J Microbiol Biotechnol; 2018 Jul; 28(7):1068-1077. PubMed ID: 29975996
[TBL] [Abstract][Full Text] [Related]
13. Engineering of
Wang ZJ; Liu X; Zhou H; Liu Y; Zhong L; Wang X; Tu Q; Huo L; Yan F; Gu L; Müller R; Zhang Y; Bian X; Xu X
Front Microbiol; 2022; 13():1073243. PubMed ID: 36466684
[TBL] [Abstract][Full Text] [Related]
14. The Disorazole Z Family of Highly Potent Anticancer Natural Products from Sorangium cellulosum: Structure, Bioactivity, Biosynthesis, and Heterologous Expression.
Gao Y; Birkelbach J; Fu C; Herrmann J; Irschik H; Morgenstern B; Hirschfelder K; Li R; Zhang Y; Jansen R; Müller R
Microbiol Spectr; 2023 Aug; 11(4):e0073023. PubMed ID: 37318329
[TBL] [Abstract][Full Text] [Related]
15. Engineered Biosynthesis of Complex Disorazol Polyketides in a Streamlined
Wang ZJ; Liu X; Zhou H; Liu Y; Tu Q; Huo L; Yan F; Müller R; Zhang Y; Xu X
ACS Synth Biol; 2023 Apr; 12(4):971-977. PubMed ID: 36988632
[TBL] [Abstract][Full Text] [Related]
16. The biosynthetic genes for disorazoles, potent cytotoxic compounds that disrupt microtubule formation.
Carvalho R; Reid R; Viswanathan N; Gramajo H; Julien B
Gene; 2005 Oct; 359():91-8. PubMed ID: 16084035
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Constitutive Promoters for the Elicitation of Secondary Metabolites in Myxobacteria.
Hu WF; Niu L; Yue XJ; Zhu LL; Hu W; Li YZ; Wu C
ACS Synth Biol; 2021 Nov; 10(11):2904-2909. PubMed ID: 34757714
[TBL] [Abstract][Full Text] [Related]
18. Myxobacteria--'microbial factories' for the production of bioactive secondary metabolites.
Wenzel SC; Müller R
Mol Biosyst; 2009 Jun; 5(6):567-74. PubMed ID: 19462013
[TBL] [Abstract][Full Text] [Related]
19. Critical variations of conjugational DNA transfer into secondary metabolite multiproducing Sorangium cellulosum strains So ce12 and So ce56: development of a mariner-based transposon mutagenesis system.
Kopp M; Irschik H; Gross F; Perlova O; Sandmann A; Gerth K; Müller R
J Biotechnol; 2004 Jan; 107(1):29-40. PubMed ID: 14687969
[TBL] [Abstract][Full Text] [Related]
20. Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via red/ET recombineering.
Wenzel SC; Gross F; Zhang Y; Fu J; Stewart AF; Müller R
Chem Biol; 2005 Mar; 12(3):349-56. PubMed ID: 15797219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
